Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 2
2000 4
2001 3
2002 4
2003 6
2004 9
2005 5
2006 10
2007 11
2008 12
2009 16
2010 21
2011 15
2012 20
2013 13
2014 20
2015 18
2016 20
2017 17
2018 22
2019 26
2020 27
2021 29
2022 25
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

PubMed for id: 483742

329 results

Results by year

Filters applied: . Clear all
Page 1
Molecular and computational characterization of ABCB11 and ABCG5 variants in Tunisian patients with neonatal/infantile low-GGT intrahepatic cholestasis: Genetic diagnosis and genotype-phenotype correlation assessment.
Khabou B, Kallabi F, Abdelaziz RB, Maaloul I, Aloulou H, Chehida AB, Kammoun T, Barbu V, Boudawara TS, Fakhfakh F, Khemakhem B, Sahnoun OS. Khabou B, et al. Ann Hum Genet. 2024 May;88(3):194-211. doi: 10.1111/ahg.12542. Epub 2023 Dec 18. Ann Hum Genet. 2024. PMID: 38108658
Progressive Familial Intrahepatic Cholestasis Type 2 and Recurrence After Liver Transplantation: A Case Report.
Romeres SGB, Trevizoli NC, Oliveira CAM, Obeid EJ, Arantes Ferreira GS, De Campos PB, Ullmann RFB, Rocha HC, Figueira AVF, Diaz LGG, Jorge FMF, Caja GON, Watanabe ALC, Sobroza de Mello E, Carvalho E. Romeres SGB, et al. Transplant Proc. 2022 Jun;54(5):1370-1375. doi: 10.1016/j.transproceed.2022.04.007. Epub 2022 Jun 17. Transplant Proc. 2022. PMID: 35718560
Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.
Loomes KM, Squires RH, Kelly D, Rajwal S, Soufi N, Lachaux A, Jankowska I, Mack C, Setchell KDR, Karthikeyan P, Kennedy C, Dorenbaum A, Desai NK, Garner W, Jaecklin T, Vig P, Miethke A, Thompson RJ. Loomes KM, et al. Hepatol Commun. 2022 Sep;6(9):2379-2390. doi: 10.1002/hep4.1980. Epub 2022 May 4. Hepatol Commun. 2022. PMID: 35507739 Free PMC article. Clinical Trial.
329 results